• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors





Cheryl D. Stults, PhD

Latest:

The Human Resource Costs of Implementing Autopend Clinical Decision Support to Improve Health Maintenance

The development and deployment of an autopend functionality within an existing health maintenance system took more than 3 years and cost $201,500 (2013 US$).


Tyler Kent, BS

Latest:

Improved Cost and Utilization Among Medicare Beneficiaries Dispositioned From the ED to Receive Home Health Care Compared With Inpatient Hospitalization

A retrospective analysis of Medicare claims was used to study emergency department (ED) dispositions, specifically evaluating inpatient admissions compared with home health referrals.


Leah M. Haverhals, MA

Latest:

E-Consult Implementation: Lessons Learned Using Consolidated Framework for Implementation Research

This paper identified 4 factors associated with implementation success of e-consults in 8 VA medical centers, with implications for implementing similar health IT initiatives elsewhere.



Richard L. Heinrich, MD

Latest:

Knowledge, Attitudes, and Preferences Regarding Advance Directives Among Patients of a Managed Care Organization

Adults 20 years or older were surveyed regarding advance directives (ADs); one third had completed an AD. Subjects were comfortable with provider initiation of the topic.



Rajul A. Patel, PharmD, PhD

Latest:

Cost Minimization of Medicare Part D Prescription Drug Plan Expenditures

Study results indicate that outreach interventions performed by trained student pharmacists assist Medicare beneficiaries to effectively navigate their Part D benefit, thereby reducing out-of-pocket costs.


Helene Vilme, DrPH

Latest:

Potential Impact of Pharmaceutical Industry Rebates on Medication Adherence

Cost is a common barrier to medication adherence. The authors discuss the potential role of medication rebates in patients’ out-of-pocket costs and medication adherence.



Bruce Pyenson, FSA, MAAA

Latest:

The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64

Screening commercially insured individuals for colorectal cancer is a high-value service, costing less per year of life saved than breast or cervical cancer screening.


Michael Silver, MS

Latest:

Trends in Public Perceptions of Electronic Health Records During Early Years of Meaningful Use

During the early years of the "meaningful use" program, surveys found decreases in both optimism and concerns about electronic health records.


Graham A. Walker, MD

Latest:

Mental Illness and Warfarin Use in Atrial Fibrillation

Atrial fibrillation patients with mental illness are less likely to receive warfarin anticoagulation; those who do receive warfarin have excess risk of over-anticoagulation.


Norman Turk, MS

Latest:

Optimizing Enrollment in Employer Health Programs: A Comparison of Enrollment Strategies in the Diabetes Health Plan

An automatic enrollment strategy for health insurance programs may not only increase the total number of enrollees but may also decrease some enrollment disparities.



Jay P. Bae, PhD

Latest:

Adherence and Dosing Frequency of Common Medications for Cardiovascular Patients

In this database analysis, greater adherence was observed for once-daily dosing compared with twice-daily dosing with chronic-use prescription medications used by patients with cardiovascular disease.


Herbert B. Olson, FSA

Latest:

The Accountable Primary Care Model: Beyond Medical Home 2.0

The new Accountable Primary Care Model delivers Triple Aim-like outcomes. This model is empirical, measurable, programmatic, scalable, and transplantable.


Dan M. Shane, PhD

Latest:

Against the Current: Back-Transfer as a Mechanism for Rural Regionalization

The authors investigated back-transfer: the transfer of patients near the end of an acute hospitalization to a local community hospital for completion of their medical care.



Kimberly J. Reid, MS

Latest:

Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.



Kevin L. Ong, PhD

Latest:

Baseline and Postfusion Opioid Burden for Patients With Low Back Pain

Patients with low back pain have a high opioid burden, which increases following spinal fusion surgery; 27% of fusion patients filled opioid prescriptions at least 12 months post surgery.



Lin Ma, MS

Latest:

Improvements in Access and Care Through the Affordable Care Act

Affordable Care Act exchange enrollees in California and Colorado reported significant improvements in access to care and fewer barriers to receiving care due to costs.



Virginia Scott, PhD

Latest:

Increased Healthcare Utilization and Expenditures Associated With Chronic Opioid Therapy

The increase in healthcare utilization and expenditures associated with the transition to chronic opioid therapy places increased burden on payers and patients.



Maria Blanco-Castellanos, RN

Latest:

Integrating Nurse-Directed Diabetes Management Into a Primary Care Setting

A nurse following treatment alogrithms with prescription authority in a primary care setting markedly improved diabetes outcomes; 47% met ADA A1C, LDL-C, and BP goals.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.